Clinical Studies on Cordyceps sinensis – Zettacare

Clinical Studies on Cordyceps sinensis

Cordyceps sinensis is commonly used together with lingzhi for strengthening the respiratory tract. Modern day research has also proven it to be clinically significantly in improving respiratory health.

  1. The inhibitory mechanism of Cordyceps sinensis on cigarette smoke extract-induced senescence in human bronchial epithelial cells (2016)Abstract: Cellular senescence is a state of irreversible growth arrest induced either by telomere shortening (replicative senescence) or stress. The bronchial epithelial cell is often injured by inhaled toxic substances, such as cigarette smoke. In the present study, we investigated whether exposure to cigarette smoke extract (CSE) induces senescence of bronchial epithelial cells; and Cordyceps sinensis mechanism of inhibition of CSE-induced cellular senescence. Cellular senescence was upregulated by CSE treatment, and C. sinensis can decrease CSE-induced cellular senescence. Activation of ROS/PI3K/AKT/mTOR signaling pathway was enhanced by CSE treatment, and decreased when C. sinensis was added. Blocking ROS/PI3K/AKT/mTOR signaling pathway can attenuate CSE-induced cellular senescence. CSE can induce cellular senescence in human bronchial epithelial cells, and ROS/PI3K/AKT/mTOR signaling pathway may play an important role in this process. C. sinensis can inhibit the CSE-induced senescence.
  2. Effectiveness and Safety of Oral Cordyceps sinensis on Stable COPD of GOLD Stages 2-3: Systemic Review and Meta-analysis (2019)Abstract: Cordyceps sinensis (CS) is a complementary medicine used for Chronic Obstructive Pulmonary Disease (COPD) of Global Initiative for Chronic Obstructive Lung Disease (GOLD) stages 2-3. Many randomized controlled trials have been conducted to evaluate the effect of CS alone or in combination with other herbs on stable COPD. To provide a synthesis of the evidence, we searched nine major electronic databases for randomized controlled trials on CS published before 21st December 2016. Fifteen interventional studies, including 1,238 participants, met the inclusion criteria. Meta-analysis showed that both CS preparations and CS formulae showed the potential benefits in lung function, exercise endurance, life quality, and improvement of symptoms. No serious adverse events were reported. So CS may be a promising treatment for patients with stable COPD of GOLD stages 2-3. No studies were placebo-controlled or of high methodological quality, which limits the conclusions.
  3. Cordyceps spp: A Review on Its Immune-Stimularory and Other biological potentials. (2021)Abstract: In recent decades, interest in the Cordyceps genus has amplified due to its immunostimulatory potential. Cordyceps species, its extracts, and bioactive constituents have been related with cytokine production such as interleukin (IL)-1β, IL-2, IL-6, IL-8, IL-10, IL-12, and tumor necrosis factor (TNF)-α, phagocytosis stimulation of immune cells, nitric oxide production by increasing inducible nitric oxide synthase activity, and stimulation of inflammatory response via mitogen-activated protein kinase pathway. Other pharmacological activities like antioxidant, anti-cancer, antihyperlipidemic, anti-diabetic, anti-fatigue, anti-aging, hypocholesterolemic, hypotensive, vasorelaxation, anti-depressant, aphrodisiac, and kidney protection, has been reported in pre-clinical studies. These biological activities are correlated with the bioactive compounds present in Cordyceps including nucleosides, sterols, flavonoids, cyclic peptides, phenolic, bioxanthracenes, polyketides, and alkaloids, being the cyclic peptides compounds the most studied. An organized review of the existing literature was executed by surveying several databanks like PubMed, Scopus, etc. using keywords like Cordyceps, cordycepin, immune system, immunostimulation, immunomodulatory, pharmacology, anti-cancer, anti-viral, clinical trials, ethnomedicine, pharmacology, phytochemical analysis, and different species names. This review collects and analyzes state-of-the-art about the properties of Cordyceps species along with ethnopharmacological properties, application in food, chemical compounds, extraction of bioactive compounds, and various pharmacological properties with a special focus on the stimulatory properties of immunity.

36 thoughts on “Clinical Studies on Cordyceps sinensis

  1. jili56 says:

    Interesting read! Fast-paced gaming is definitely the trend now. Seeing platforms like Jili56 prioritize speed & easy access-check out the jili56 apk-is smart. The quick verification sounds great for getting right into the action!

  2. jiliaaaph says:

    It’s great seeing platforms like this prioritize easy access & localized payment options – like GCash! Responsible gaming is key, and a smooth experience helps. Check out this jiliaaa ph link for a quick signup – under 2 mins! Remember to play within your limits. 😊

  3. ketqua888 says:

    What’s the deal, everyone? I hit up ketqua888 just the other day, and it looks like an alright spot. Gotta compare it to your usual haunts, but it wasn’t terrible. Give it a try at ketqua888.

  4. oxplay says:

    Dice games are fascinating – the probabilities are surprisingly complex! Seeing platforms like oxplay games offer such a wide variety, including live casino options, is really cool. Instant PHP deposits via GCash are a game changer too! 🎲✨

  5. super85 says:

    What’s up folks? I’ve been testing out super85 recently and I’m liking the vibe. It’s straightforward and has some cool promotions. Take a look at super85 when you get a chance.

  6. jiliph says:

    The research on Cordyceps sinensis inhibiting CSE-induced cellular senescence through the ROS/PI3K/AKT/mTOR pathway is groundbreaking. As someone who analyzes health tech platforms, I see parallels between how botanical compounds work synergistically – similar to how integrated gaming ecosystems operate. For comprehensive digital wellness platforms, check jiliph app download apk for community engagement.

  7. 29betcom says:

    Been using 29betcom for a while now, and honestly, it’s got a decent selection of games. Payouts are usually pretty quick too, which is a big plus. Worth a look if you’re after something new. Here’s the link: 29betcom

  8. 199winbet says:

    Hey everyone, been trying my luck at 199winbet.info lately. It’s got a decent selection of games, nothing mind-blowing, but solid. The interface is pretty intuitive too. Definitely worth a look for a quick flutter. Check it out: 199winbet

  9. 33wim says:

    Interesting points about bankroll management! Seeing platforms like 33wim casino embrace tech-biometrics & smart payments-could really streamline the player experience & build trust at the tables. Good stuff!

  10. kubetjudaism says:

    Been hanging out on Kubetjudaism lately. It’s alright, has its ups and downs like any other site. But I’ve had some laughs, for sure. So yeah, check it out if you’re looking for something new. Good luck! kubetjudaism.

  11. p9betbr says:

    P9betbr, okay, I see you! Pretty solid interface and the odds seem competitive. If you’re searching for a reliable betting platform, this could be it. Definitely worth exploring if you’re in Brazil. Visit p9betbr to get started.

  12. gt777slot says:

    Heard about GT777slot from a buddy. Gave it a whirl, and honestly, the signup was pretty smooth. The slots are alright, nothing groundbreaking, but they kept me entertained for a bit. I’d say give it a shot if you’re bored. Check it out here: gt777slot

  13. 9xbetwin says:

    9xbetwin, huh? I’ve seen it pop up a few times. The sports betting odds looked pretty competitive, so I threw a few bucks down on a game. Won a bit, cashed out okay. Site design is… functional. See for yourself at: 9xbetwin

  14. ck888vip says:

    Someone mentioned CK888vip in a forum. Figured I’d have a look. Seems like they focus a lot on VIP stuff (obviously!). Didn’t go too deep, but the bonuses looked decent enough at first glance. Maybe worth checking out if you’re a high roller: ck888vip

Leave a Reply

Your email address will not be published. Required fields are marked *